Research Paper Volume 14, Issue 12 pp 5211—5222

Figure 3. The correlation between SNX20 expression and clinical information in LGG. (A–E) The correlation between SNX20 expression and clinical features, including the higher tumor grades, histological type, IDH mutation status, 1p/19q chromosome co-deletion and primary therapy outcome. (F, G) ROC analyses revealed the predictive value of SNX20 in glioma based on TCGA-LGG. (H–K) The overall survival, disease specific survival and progression free survival of SNX20 in LGG examined by TCGA and CGGA database. Primary therapy outcome: including PD: progressive disease. SD: stable disease.